Blogs

The CMS's Center for Medicare and Medicaid Innovation (CMMI) recently announced the strategic redesign of their current Global and Professional Direct Contracting (GPDC) model.

Meet Joe. He’s a 68-year-old who suffers from chronic obstructive pulmonary disease (COPD).

Today’s special guest, Dr. Subir Roy, Takeda’s Associate Director of Global Medical Affairs, has been at the intersection of pharma, commercial strategy, data, and technology helping drive greater results in drug development, commercialization, and patient outcomes.

Why should biopharma think beyond point solutions to truly change care for the better? A new advisory in STAT has the answers.

The healthcare industry is transitioning to value-based care models. That’s why the medical device industry's ability to continue the development of life-changing innovations will rely on demonstrating how new technology fits under the new value-based paradigm.

While artificial intelligence has already shown value in reducing healthcare costs and improving patient care, certain challenges must be overcome before the next wave of adoption.